Spatial multiomics of arterial regions from cardiac allograft vasculopathy rejected grafts reveal novel insights into the pathogenesis of chronic antibody-mediated rejection

Am J Transplant. 2024 Jul;24(7):1146-1160. doi: 10.1016/j.ajt.2024.01.004. Epub 2024 Jan 12.

Abstract

Cardiac allograft vasculopathy (CAV) causes late graft failure and mortality after heart transplantation. Donor-specific antibodies (DSAs) lead to chronic endothelial cell injury, inflammation, and arterial intimal thickening. In this study, GeoMx digital spatial profiling was used to analyze arterial areas of interest (AOIs) from CAV+DSA+ rejected cardiac allografts (N = 3; 22 AOIs total). AOIs were categorized based on CAV neointimal thickening and underwent whole transcriptome and protein profiling. By comparing our transcriptomic data with that of healthy control vessels of rapid autopsy myocardial tissue, we pinpointed specific pathways and transcripts indicative of heightened inflammatory profiles in CAV lesions. Moreover, we identified protein and transcriptomic signatures distinguishing CAV lesions exhibiting low and high neointimal lesions. AOIs with low neointima showed increased markers for activated inflammatory infiltrates, endothelial cell activation transcripts, and gene modules involved in metalloproteinase activation and TP53 regulation of caspases. Inflammatory and apoptotic proteins correlated with inflammatory modules in low neointima AOIs. High neointima AOIs exhibited elevated TGFβ-regulated transcripts and modules enriched for platelet activation/aggregation. Proteins associated with growth factors/survival correlated with modules enriched for proliferation/repair in high neointima AOIs. Our findings reveal novel insight into immunological mechanisms mediating CAV pathogenesis.

MeSH terms

  • Allografts
  • Biomarkers / metabolism
  • Female
  • Follow-Up Studies
  • Gene Expression Profiling
  • Graft Rejection* / etiology
  • Graft Rejection* / immunology
  • Graft Rejection* / pathology
  • Graft Survival / immunology
  • Heart Transplantation* / adverse effects
  • Humans
  • Isoantibodies / immunology
  • Male
  • Middle Aged
  • Multiomics
  • Neointima / etiology
  • Neointima / immunology
  • Neointima / pathology
  • Prognosis
  • Tissue Donors
  • Transcriptome
  • Vascular Diseases / etiology
  • Vascular Diseases / immunology
  • Vascular Diseases / pathology

Substances

  • Isoantibodies
  • Biomarkers